Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Renal cell carcinoma
ADR ID BADD_A06472
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.08      Renal and urinary tract neoplasms malignant and unspecified
16.08.02      Renal neoplasms malignant
16.08.02.002      Renal cell carcinoma
20      Renal and urinary disorders
20.01      Renal disorders (excl nephropathies)
20.01.04      Renal neoplasms
20.01.04.003      Renal cell carcinoma
Description A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. [MeSH]
MedDRA Code 10067946
MeSH ID D002292
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Adenocarcinoma of kidney | Granular cell carcinoma of the kidney | Hypernephroma | Renal cell adenocarcinoma | Renal cell cancer | Renal cell carcinoma NOS | Renal cell carcinoma stage unspecified | Renal granular cell carcinoma | Collecting duct renal cancer | Renal cell carcinoma with sarcomatoid features | Hypernephroid tumor | Renal cell carcinoma | Hypernephroid tumour | Grawitz tumor | Grawitz tumour | Carcinoma of the collecting ducts of Bellini | Advanced renal cell carcinoma | Carcinoma, Renal Cell | Carcinomas, Renal Cell | Renal Cell Carcinomas | Adenocarcinoma, Renal Cell | Adenocarcinomas, Renal Cell | Renal Cell Adenocarcinoma | Renal Cell Adenocarcinomas | Adenocarcinoma Of Kidney | Adenocarcinoma Of Kidneys | Kidney, Adenocarcinoma Of | Kidneys, Adenocarcinoma Of | Renal Cell Cancer | Cancer, Renal Cell | Cancers, Renal Cell | Renal Cell Cancers | Adenocarcinoma, Renal | Adenocarcinomas, Renal | Renal Adenocarcinoma | Renal Adenocarcinomas | Nephroid Carcinoma | Carcinoma, Nephroid | Carcinomas, Nephroid | Nephroid Carcinomas | Renal Cell Carcinoma | Chromophobe Renal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Renal Cell Carcinoma, Papillary | Chromophil Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | Grawitz Tumor | Tumor, Grawitz | Clear Cell Renal Carcinoma | Carcinoma, Hypernephroid | Carcinomas, Hypernephroid | Hypernephroid Carcinoma | Hypernephroid Carcinomas | Hypernephromas | Collecting Duct Carcinoma (Kidney) | Carcinoma, Collecting Duct (Kidney) | Carcinomas, Collecting Duct (Kidney) | Collecting Duct Carcinomas (Kidney) | Collecting Duct Carcinoma of the Kidney | Renal Collecting Duct Carcinoma | Collecting Duct Carcinoma | Carcinoma, Collecting Duct | Carcinomas, Collecting Duct | Collecting Duct Carcinomas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00023Acetaminophen--
BADD_D00193Axitinib0.011249%
BADD_D00284Bortezomib--
BADD_D00330Cabozantinib0.009962%
BADD_D00497Clomiphene--
BADD_D00498Clomiphene citrate--
BADD_D00549Cyclophosphamide--
BADD_D00680Dimethyl fumarate0.002080%
BADD_D00774Entecavir0.004903%
BADD_D00858Everolimus0.002278%
BADD_D00879Fentanyl0.000211%
BADD_D01133Ifosfamide--
BADD_D01136Imatinib0.000280%
BADD_D01245Lansoprazole0.000099%
BADD_D01303Lithium carbonate0.001338%
BADD_D01304Lithium cation0.000576%
BADD_D01418Methotrexate--
BADD_D01506Muromonab-cd3--
BADD_D01687Pazopanib0.004667%
BADD_D01765Phenytoin0.000191%
BADD_D01858Propagermanium--
BADD_D01913Ranitidine--
BADD_D02029Sitagliptin0.000053%
BADD_D02058Sorafenib0.004197%
BADD_D02100Sunitinib0.026113%
BADD_D02154Tenofovir0.002908%
BADD_D02237Tofacitinib citrate--
BADD_D02331Valsartan0.000159%
BADD_D02375Water--
BADD_D02392Zoledronic acid--
The 1th Page    1 2    Next   Last    Total 2 Pages